PFKM and familial pancreatic carcinoma: KRAS plays an important role in driving glycolysis in pancreatic cancer, leading to progression of the disease by increasing GLUT1, hexokinase II (HK II), and phosphofructokinase 1 (PFK1) expression (151–154).